Document Detail

Screening for hyperglycaemia in pregnancy: Consensus and controversy.
MedLine Citation:
PMID:  20832736     Owner:  NLM     Status:  MEDLINE    
Policy decisions on whether to implement screening programmes depend on whether the proposed programmes meet a set of criteria laid down by the World Health Organization. Screening for hyperglycaemia in pregnancy (HGP) does not meet all the criteria. However the case for screening has been strengthened by a number of recent developments, including: rising prevalence of HGP because of increasing maternal age and BMI; the results of the Hyperglycaemia and Adverse Pregnancy Outcomes study, showing that adverse effects of HGP are seen over a wider range of plasma glucose levels than previously thought; two large trials which showed the benefits of treating lesser degrees of HGP; trials showing that metformin and glibenclamide were effective and safe alternatives to immediate insulin in those without good control on lifestyle measures alone. However uncertainties remain around the threshold for treatment, and on the best screening strategy.
Norman Waugh; Donald Pearson; Pamela Royle
Related Documents :
23438156 - Metabolic syndrome in normal and complicated pregnancies.
9795786 - Screening pregnant women for group b streptococcal colonization.
15319826 - Clinical application of inhibin a measurement: prenatal serum screening for down syndrome.
24465936 - Reduced fetal telomere length in gestational diabetes.
3987966 - Gonadotropins and the timing of progesterone-induced meiotic maturation of xenopus laev...
10396466 - Relative importance of heritable characteristics and lifestyle in the development of ma...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Best practice & research. Clinical endocrinology & metabolism     Volume:  24     ISSN:  1878-1594     ISO Abbreviation:  Best Pract. Res. Clin. Endocrinol. Metab.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2011-01-07     Revised Date:  2012-11-07    
Medline Journal Info:
Nlm Unique ID:  101120682     Medline TA:  Best Pract Res Clin Endocrinol Metab     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  553-71     Citation Subset:  IM    
Copyright Information:
2010. Published by Elsevier Ltd. All rights reserved.
Department of Public Health Medical School Buildings, Foresterhill, Aberdeen, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Mass Index
Diabetes, Gestational / diagnosis*,  epidemiology
Glucose Tolerance Test / methods
Great Britain / epidemiology
Hyperglycemia / diagnosis*
Mass Screening / economics,  standards*
Maternal Age
United States / epidemiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Developmental programming and diabetes - The human experience and insight from animal models.
Next Document:  The maternal and fetal impacts of obesity and gestational diabetes on pregnancy outcome.